产品编号 :
Cas No. :
CAS No. |
1231889-53-4 |
|---|---|
中文名称 |
BMS-935177(研发代号,非IUPAC系统命名;需提供该化合物的结构式/SMILES/InChI或完整英文系统命名以生成符合CCS的中文系统名) |
英文名称 |
BMS-935177 |
别名 |
9H-Carbazole-1-carboxamide, 7-(1-hydroxy-1-methylethyl)-4-[2-methyl-3-(4-oxo-3(4H)-quinazolinyl)phenyl]-;7-(2-Hydroxypropan-2-yl)-4-(2-methyl-3-(4-oxoquinazolin-3(4H)-yl)phenyl)-9H-carbazole-1-carboxamide;BMS 935177,BMS935177;BMS-935177, 10 mM in DMSO;BI-BTK-1 |
标准英文名 |
7-(2-hydroxypropan-2-yl)-4-(2-methyl-3-(4-oxoquinazolin-3(4H)-yl)phenyl)-9H-carbazole-1-carboxamide |
分子式 |
C31H26N4O3 |
分子量 |
502.57 |
精确分子量 |
502.20 |
SMILES |
O=C(C1=CC=C(C2=CC=CC(N3C=NC4=C(C=CC=C4)C3=O)=C2C)C5=C1NC6=C5C=CC(C(C)(O)C)=C6)N |
标准SMILES |
CC1C(=CC=CC=1N1C=NC2C=CC=CC=2C1=O)C1=CC=C(C(N)=O)C2NC3C=C(C=CC=3C=21)C(C)(C)O |
用途 |
BMS-935177 is a potent and reversible Bruton's tyrosine kinase (BTK) inhibitor with an IC50 of 2.8 nM and high kinase selectivity; it is 5- to 67-fold more selective for BTK over other kinases such as TEC, BMX, ITK, and TXK; it inhibits calcium flux in Ramos B cells and suppresses cell surface expression of CD69 in human peripheral blood B lymphocytes stimulated with anti-IgM and anti-IgG (but not in B cells activated via CD40 receptor-ligand interaction); it effectively inhibits TNF-α production in human peripheral blood mononuclear cells (PBMCs) with an IC50 of 14 nM; it demonstrates good oral bioavailability (84–100%) in rats, mice, dogs, and cynomolgus monkeys when administered as a solution, despite poor aqueous solubility; it exhibits low systemic clearance and long half-lives (4 h in mice and 5.1 h in rats) following intravenous administration at 2 mg/kg. |
InChIKey |
TVJRDCQUZMGBAB-UHFFFAOYSA-N |
|
|
评论 |
|---|